Fipronil/Cyphenothrin Flea / Tick Product

Verify with FDA CVM →

31 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
31
Total Reports
2
Deaths Reported
650.0%
Death Rate

Active Ingredients

Fipronil/Cyphenothrin Flea / Tick Product

Administration Routes

UnknownTopical

Species Affected

Dog 31

Most Affected Breeds

Retriever - Labrador 7
Retriever - Golden 3
Shih Tzu 2
Pug 2
Cattle Dog - Flanders (Bouvier) 2
Maltese 2
Coton de Tuléar 1
Dachshund - Miniature 1
Pointing Dog - German Short-haired 1
Bulldog - American 1

Most Reported Reactions

Vomiting 12
Other abnormal test result NOS 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Elevated alanine aminotransferase (ALT) 3
Elevated serum alkaline phosphatase (SAP) 3
Lack of efficacy - NOS 3
Diarrhoea 3
Behavioural disorder NOS 2
Seizure NOS 2
Decreased appetite 2
Loose stool 2
Fever 2

Outcome Breakdown

Ongoing
22 (71.0%)
Recovered/Normal
6 (19.4%)
Died
2 (6.5%)
Outcome Unknown
1 (3.2%)

Data Summary

Metric Value
Total adverse event reports 31
Reports involving death 2
Case-fatality rate (reported events) 650.0%
Distinct species in reports 1
Distinct breeds in reports 19
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fipronil/Cyphenothrin Flea / Tick Product Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 31 adverse event reports referencing Fipronil/Cyphenothrin Flea / Tick Product, including 2 reports in which the animal died — a 650.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fipronil/Cyphenothrin Flea / Tick Product. Reported administration routes include Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fipronil/Cyphenothrin Flea / Tick Product reports are Dog (31 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (7), Retriever - Golden (3), Shih Tzu (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fipronil/Cyphenothrin Flea / Tick Product are Vomiting (12), Other abnormal test result NOS (5), Lethargy (see also Central nervous system depression in 'Neurological') (4), Elevated alanine aminotransferase (ALT) (3). Of the 31 reports with a coded outcome, Ongoing is the leading category at 71.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fipronil/Cyphenothrin Flea / Tick Product.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial